Clinical Trial: A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Subjects

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06932315) titled 'A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Subjects' on April 10.

Brief Summary: This is a single-center, open-label and dose-escalation study to evaluate the safety, tolerability and dose-response relationship of HRS-9190 in healthy adults.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Skeletal Muscle Relaxation

Intervention: DRUG: HRS-9190 for Injection

Subject will receive the HRS-9190 injection at different dose levels.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Published by HT Digital Content Services...